Literature DB >> 23563566

Hypoallergenicity and immunological characterization of enzyme-treated royal jelly from Apis mellifera.

Tatsuya Moriyama1, Miyako Yanagihara, Erika Yano, Goro Kimura, Mariko Seishima, Hiroko Tani, Tomoko Kanno, Tooru Nakamura-Hirota, Ken Hashimoto, Tomoki Tatefuji, Tadashi Ogawa, Yukio Kawamura.   

Abstract

Royal jelly (RJ), the exclusive food for queen bees, is taken as a dietary supplement because it is highly rich in nutrients. However, RJ is known to induce an anaphylactic response in some individuals. We evaluated in the present study the hypoallergenicity of alkaline protease-treated RJ in vitro and in vivo. We first confirmed that this treated RJ contained the same levels of vitamins, minerals and specific fatty acid as in untreated RJ. We then showed that the IgE-binding capacity of the treated RJ was very significantly reduced by conducting in vitro assays of the blood from RJ-sensitive patients. An in vivo skin-prick test on the RJ-sensitive patients also showed that, in the majority of the patients (3 out of 4 tested), the treated RJ did not evoke any allergenic response. It is thus advantageous to prepare hypoallergenic RJ by a protease enzyme treatment for its safe consumption.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23563566     DOI: 10.1271/bbb.120924

Source DB:  PubMed          Journal:  Biosci Biotechnol Biochem        ISSN: 0916-8451            Impact factor:   2.043


  7 in total

1.  Royal jelly promotes DAF-16-mediated proteostasis to tolerate β-amyloid toxicity in C. elegans model of Alzheimer's disease.

Authors:  Xiaoxia Wang; Min Cao; Yuqing Dong
Journal:  Oncotarget       Date:  2016-08-23

Review 2.  New Insights into the Biological and Pharmaceutical Properties of Royal Jelly.

Authors:  Saboor Ahmad; Maria Graça Campos; Filippo Fratini; Solomon Zewdu Altaye; Jianke Li
Journal:  Int J Mol Sci       Date:  2020-01-08       Impact factor: 5.923

3.  Royal Jelly Protects against Epidermal Stress through Upregulation of the NQO1 Expression.

Authors:  Nobuaki Okumura; Takashi Ito; Tomomi Degawa; Mariko Moriyama; Hiroyuki Moriyama
Journal:  Int J Mol Sci       Date:  2021-11-30       Impact factor: 5.923

4.  Metabolism and pharmacokinetics of medium chain fatty acids after oral administration of royal jelly to healthy subjects.

Authors:  Masayuki Yamaga; Hiroko Tani; Ayanori Yamaki; Tomoki Tatefuji; Ken Hashimoto
Journal:  RSC Adv       Date:  2019-05-17       Impact factor: 4.036

5.  Royal Jelly Delays Motor Functional Impairment During Aging in Genetically Heterogeneous Male Mice.

Authors:  Nobuaki Okumura; Toshihiko Toda; Yusuke Ozawa; Kenji Watanabe; Tomoki Ikuta; Tomoki Tatefuji; Ken Hashimoto; Takahiko Shimizu
Journal:  Nutrients       Date:  2018-09-01       Impact factor: 5.717

6.  Daily Oral Administration of Protease-Treated Royal Jelly Protects Against Denervation-Induced Skeletal Muscle Atrophy.

Authors:  Tomohiko Shirakawa; Aki Miyawaki; Takuma Matsubara; Nobuaki Okumura; Hideto Okamoto; Naoya Nakai; Thira Rojasawasthien; Kazumasa Morikawa; Asako Inoue; Akino Goto; Ayako Washio; Toshiyuki Tsujisawa; Tatsuo Kawamoto; Shoichiro Kokabu
Journal:  Nutrients       Date:  2020-10-11       Impact factor: 5.717

Review 7.  Apitherapy for Parkinson's Disease: A Focus on the Effects of Propolis and Royal Jelly.

Authors:  Amira Mohammed Ali; Hiroshi Kunugi
Journal:  Oxid Med Cell Longev       Date:  2020-10-17       Impact factor: 6.543

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.